Skip to content

Effects of Forest Therapy on Physical and Psychological Parameters in the General Population - a Randomized Controlled Trial

Effects of Forest Therapy on Physical and Psychological Parameters in the General Population - a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05562128
Enrollment
120
Registered
2022-09-30
Start date
2022-10-10
Completion date
2025-08-31
Last updated
2025-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Population (no Specific Condition or Disease)

Brief summary

In recent years, nature and forest therapy has increasingly become the focus of medical research. Recent scientific findings indicate overall positive effects of nature and forest therapy on physical and mental health. In Asia and Australia, it has already been implemented as a public health concept of prevention and health promotion. The aim of the project is to replicate the experience gained in Asia over the last three decades on the physical and psychological effects of nature/forest therapy in the context of the German forest and to investigate it further scientifically.

Interventions

BEHAVIORALActive forest therapy

Participants take part in a two-hour active clinical forest therapy in Berlin-Wannsee on two days (with a break day in between). In this setting, a trained clinical forest therapist teaches exercises on the perception of nature and the connection between nature and health.

BEHAVIORALPassive forest therapy

Participants take part in a two-hour passive clinical forest therapy in Berlin-Wannsee over two days (with a break day in between). In this setting, a trained clinical forest therapist will guide participants to various locations in the forest where participants can stay and let nature have its effect on them.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

\- Ability to Consent

Exclusion criteria

* Serious acute or chronic illness * Immobility or limitation of mobility due to orthopedic, neurologic, or other medical causes * Participation in another study * Serious mental illness * Pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
Profile of Mood States (POMS)Change from baseline POMS score at 3 months

Secondary

MeasureTime frameDescription
Profile of Mood States (POMS)Baseline, day 1, day 3, 1 week, 3 months
Perceived Benefits of Nature Questionnaire (PBNQ)Baseline, 1 week, 3 months
Subjective Vitality Scale state (SVS-G state)Baseline, day 1, day 3, 1 week, 3 months
Complaint List (B-LR)Baseline, 1 week, 3 months
Perceive Stress Questionaire (PSQ)Baseline, day 1, day 3, 1 week, 3 months
Freiburger Fragebogen zur Achtsamkeit (FFA)Baseline, 1 week, 3 months
State-Trait Anxiety Inventory (STAI)Baseline, day 1, day 3, 1 week, 3 monthsThe scale ranges from 1 to 8. Higher scores correspond to higher levels of anxiety (after recoding three inverted items).
PROMIS Scale v1.2 - Global HealthBaseline, 1 week, 3 monthsThe scale ranges from 1 to 5, where 1 is the lowest level and 5 is the highest level. Higher scores reflect better functioning.
Hospital Anxiety and Depression Scale (HADS)Baseline, 1 week, 3 monthsThe scale ranges from 0 to 3. Higher scores correspond to higher levels of anxiety and/or depression.
Perceived Stress Scale (PSS)Baseline, 1 week, 3 monthsThe scale ranges from 0 to 4. Higher scores correspond to higher levels of perceived stress.
Allgemeine Selbstwirksamkeit Kurzskala (ASKU)Baseline, 1 week, 3 monthsThe scale ranges from 1 to 5. Higher scores correspond to better outcomes.

Other

MeasureTime frameDescription
Heart Rate Variability (HRV)Baseline, 1 week24h measuring by Faros 180
Qualitative interviews1 week and 8 weeks after inclusionQualitative assessment will be carried out in qualitative interviews in 20 patients participating in the study. The interviews will be recorded, transcribed and analyzed with qualitative content analysis.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026